Design, Synthesis, and Biological Evaluation of Novel Simvastatin Derivatives with Potent Lipid-Lowering Effects and HMG-CoA Reductase Inhibition in Hyperlipidemic Rats

Amaal Hussein Sheaa; Abass Fadhil Abass; Sameera Ahmed Zearah

doi:10.22146/ijc.108172

Design, Synthesis, and Biological Evaluation of Novel Simvastatin Derivatives with Potent Lipid-Lowering Effects and HMG-CoA Reductase Inhibition in Hyperlipidemic Rats

https://doi.org/10.22146/ijc.108172

Amaal Hussein Sheaa⁽¹⁾, Abass Fadhil Abass⁽²⁾, Sameera Ahmed Zearah^(3*)

(1) Department of Medical Laboratory Techniques, College of Health and Medical Technologies, Southern Technical University, Zubair Road, Basrah 61006, Iraq
(2) Department of Chemistry, College of Science, University of Basrah, Qarmat Ali, Basrah 61004, Iraq
(3) Department of Chemistry, College of Science, University of Basrah, Qarmat Ali, Basrah 61004, Iraq
(*) Corresponding Author

Abstract

In this study, two novel ester derivatives of simvastatin were synthesized via a convenient one-pot esterification method using acetic acid and propanoic acid. The synthesized compounds were fully characterized by FTIR, ¹H-NMR, ¹³C-NMR, and mass spectrometry. Their safety profiles were evaluated through acute toxicity (LD₅₀) and cytotoxicity tests, affirming their biocompatibility. To assess their hypolipidemic potential, both derivatives (A1 and A2) were administered to a cholesterol-induced hyperlipidemic rat model. Lipid profiles, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very low-density lipoprotein (VLDL), were measured post-treatment. The results revealed that both compounds significantly improved lipid parameters, with the propanoate derivative (A2) exhibiting the most potent lipid-lowering activity, surpassing even the reference drug, simvastatin. Furthermore, biochemical assays demonstrated a substantial reduction in hepatic HMG-CoA reductase activity, particularly in the A4-treated group, suggesting a direct inhibitory effect on cholesterol biosynthesis. These findings suggest that the synthesized derivatives may serve as promising candidates for the development of safer and more effective lipid-lowering agents.

Keywords

simvastatin derivatives; hypercholesterolemia; lipid profile; statin analogs

Full Text:

Full Text PDF Full Text PDF-Suppl. Data

References

[1] Safapoor, S., Yazdani, H., and Shahabi, P., 2020, A review on synthesis and applications of statin family drugs as a new generation of anti-blood medicines, J. Chem. Rev., 2 (1), 1–27.

[2] Su, X., Zhang, L., Lv, J., Wang, J., Hou, W., Xie, X., and Zhang, H., 2016, Effect of statins on kidney disease outcomes: A systematic review and meta-analysis, Am. J. Kidney Dis., 67 (6), 881–892.

[3] Lumbantoruan, L., Sinaga, E., Simanjuntak, K., Nurbaya, S., and Prasasty, V.D., 2024, Potential of flavonoid compounds from Rhodomyrtus tomentosa as anticholesterol: An in silico study, J. Trop. Biodiversity, 4 (3), 124–132.

[4] Abdelghany, A.E., El-Garhy, O., and Elbarbary, H., 2023, Critical appraisal of physiochemical characteristics of statins and drug delivery systems for improving their bioavailability, J. Adv. Biomed. Pharm. Sci., 6 (1), 16–24.

[5] dos Santos Fernandes, G.F., Prokopczyk, I.M., Chin, C.M., and dos Santos, J.L., 2020, “The Progress of Prodrugs in Drug Solubility” in Recent Advancement in Prodrugs, Eds. Shah, K., Chauhan, D.N., Chauhan N.S., and Mishra, P., CRC Press, Boca Raton, FL, US, 133–164.

[6] Li, J., 2024, Advances and applications of prodrug strategies in drug design, J. Food Sci., Nutr. Health, 3, 12–22.

[7] Farshori, N.N., Banday, M.R., Zahoor, Z., and Rauf, A., 2010, DCC/DMAP mediated esterification of hydroxy and non-hydroxy olefinic fatty acids with β-sitosterol: In vitro antimicrobial activity, Chin. Chem. Lett., 21 (6), 646–650.

[8] Vilas Bôas, R.N., and de Castro, H.F., 2021, A review of synthesis of esters with aromatic, emulsifying, and lubricant properties by biotransformation using lipases, Biotechnol. Bioeng., 119 (3), 725–742.

[9] Laddha, P.R., Sitaphale, G.R., Charhate, K.B., and Tathe, P.R., 2024, Green chemistry in pharmaceutical synthesis: Sustainable strategies for drug production, Int. J. Adv. Res. Sci., Commun. Technol., 4 (2), 323–330.

[10] Sardarian, A.R., Zandi, M., and Motevally, S., 2009, One-pot synthesis of carboxylic acid esters in neutral and mild conditions by triphenylphosphine dihalide (Ph₃PX₂, X=Br, I), Acta Chim. Slov., 56, 729–733.

[11] Brage, M.A., AL Zobidy, A.M., and Al-Masoudi, W.A., 2022, Synthesis, characterization, acute toxicity and investigation of the new pyrimidine derivative as antihyperlipidemic activity on male mice, Basrah J. Vet. Res., 21 (S1), 113–124.

[12] Gothe, M.P., Pawade, U.V., Nikam, A.V., and Anjankar, A.M., 2023, OECD guidelines for acute oral toxicity studies: An overview, Int. J. Res. Ayurveda Pharm., 14 (4), 137–140.

[13] Al-Atbi, H.S., Al-Assadi, I.J., Al-Salami, B.K., and Badr, S.Q., 2020, Study of new azo-azomethine derivatives of sulfanilamide: Synthesis, characterization, spectroscopic, antimicrobial, antioxidant and anticancer activity, Biochem. Cell. Arch., 20 (Suppl. 2), 4161–4174.

[14] Mustafa, T., and Abdulah, H., 2019, Histological alterations induced by atorvastatin therapeutic doses in some organs of male albino rats, Polytechn. J., 9 (1), 4.

[15] Suker, D.K., Thamer, S.J., and Al Taha, T.J., 2013, The effect of maternal diet prior and during pregnancy in rats on obesity development in offspring, Eur. J. Exp. Biol., 3 (1), 191–198.

[16] Al-Fartosy, A.J., Zearah, S.A., and Alwan, N.A., 2013, Total antioxidant capacity and antihyperlipidemic activity of alkaloid extract from aerial part of Anethum graveolens L. plant, Eur. Sci. J., 9 (33), 413–423.

[17] Varghese, R., Anoop, S., Venugopal, S.K., Sooryadas, S., Vasudevan, V.N., Panicker, V.P., Nair, S.S., Jennes, D., and John Martin, K.D., 2025, Modified syringe technique to prepare platelet rich plasma from rat blood, its quantitative assessment, and evaluation of platelets stored at 4 °C to determine its suitability for homologous application, J. Vet. Anim. Sci., 56 (1), 13–19.

[18] El Nabetiti, S., Eleiwa, N.Z., Kamel, M.A., and Fahmy, A.A., 2023, Hyperlipidemia: Methods of induction and possible treatments, Zagazig Vet. J., 51 (2), 169–184.

[19] Fu, L., Ren, H., Wang, C., Zhao, Y., Zou, B., and Zhang, X., 2025, Formation of PEG-PLGA microspheres for controlled release of simvastatin and carvacrol: Enhanced lipid-lowering efficacy and improved patient compliance in hyperlipidemia therapy, Polymers, 17 (5), 574.

[20] Li, Y., Wu, Y., Li, Y.J., Meng, L., Ding, C.Y., and Dong, Z.J., 2019, Effects of silymarin on the in vivo pharmacokinetics of simvastatin and its active metabolite in rats, Molecules, 24 (9), 1666.

[21] Chaen, H., Kinchiku, S., Miyata, M., Kajiya, S., Uenomachi, H., Yuasa, T., Takasaki, K., and Ohishi, M., 2016, Validity of a novel method for estimation of low-density lipoprotein cholesterol levels in diabetic patients, J. Atheroscler. Thromb., 23 (12), 1355–1364.

[22] Lau, C.S., Loh, W.J., and Aw, T.C., 2021, A contemporary evaluation of calculated and directly measured LDL, Jpn. J. Clin. Med. Res., 1 (2), 1–11.

[23] Sardarian, A.R., Zandi, M., and Motevally, S., 2009, One-pot synthesis of carboxylic acid esters in neutral and mild conditions by triphenylphosphine dihalide [Ph₃PX₂ (X=Br, I)], Acta Chim. Slov., 56, 729–733.

[24] Brahmaiah, B., Desu, P.K., Nama, S., Khalilullah, S., and Babu, S.S., 2013, Formulation and evaluation of extended release mucoadhesive microspheres of simvastatin, Int. J. Pharm. Biomed. Res., 4 (1), 57–64.

[25] Rakhmatullin, I.Z., Galiullina, L.F., Klochkova, E.A., Latfullin, I.A., Aganov, A.V., and Klochkov, V.V., 2016, Structural studies of pravastatin and simvastatin and their complexes with SDS micelles by NMR spectroscopy, J. Mol. Struct., 1105, 25–29.

[26] Andrews, D.L., 2015, Laser spectroscopy 1: Basic principles & laser spectroscopy 2: Experimental techniques (5^th edition), Contemp. Phys., 56 (4), 487–488.

[27] Wong, K.C., 2015, Review of spectrometric identification of organic compounds, 8^th edition, J. Chem. Educ., 92 (10), 1602–1603.

[28] Tete, V.S., Nyoni, H., Mamba, B.B., and Msagati, T.A.M., 2020, Occurrence and spatial distribution of statins, fibrates and their metabolites in aquatic environments, Arabian J. Chem., 13 (2), 4358–4373.

[29] Ouimet, M., Barrett, T.J., and Fisher, E.A., 2019, HDL and reverse cholesterol transport, Circ. Res., 124 (10), 1505–1518.

[30] Temml, V., and Kutil, Z., 2021, Structure-based molecular modeling in SAR analysis and lead optimization, Comput. Struct. Biotechnol. J., 19, 1431–1444.

[31] Markowska, A., Antoszczak, M., Markowska, J., and Huczyński, A., 2020, Statins: HMG-CoA reductase inhibitors as potential anticancer agents against malignant neoplasms in women, Pharmaceuticals, 13 (12), 422.

[32] Jomard, A., and Osto, E., 2020, High density lipoproteins: Metabolism, function, and therapeutic potential, Front. Cardiovasc. Med., 7, 39.

[33] Elis, A., 2023, Current and future options in cholesterol lowering treatments, Eur. J. Intern. Med., 112, 1–5.

[34] Yang, L., Qin, X., Gong, M., Jiang, X., Yang, M., Li, X., and Li, G., 2014, Improving surface-enhanced Raman scattering properties of TiO₂ nanoparticles by metal Co doping, Spectrochim. Acta, Part A, 123, 224–229.

[35] Li, Z., Zhang, J., Zhang, Y., and Zuo, Z., 2019, Role of esterase mediated hydrolysis of simvastatin in human and rat blood and its impact on pharmacokinetic profiles of simvastatin and its active metabolite in rat, J. Pharm. Biomed. Anal., 168, 13–22.

[36] Cui, D., Yu, X., Guan, Q., Shen, Y., Liao, J., Liu, Y., and Su, Z., 2025, Cholesterol metabolism: Molecular mechanisms, biological functions, diseases, and therapeutic targets, Mol. Biomed., 6 (1), 72.

[37] Gesto, D.S., Pereira, C.M.S., Cerqueira, N.M.F.S., and Sousa, S.F., 2020, An atomic-level perspective of HMG-CoA-reductase: The target enzyme to treat hypercholesterolemia, Molecules, 25 (17), 3891.

[38] Hu, N., Chen, C., Wang, J., Huang, J., Yao, D., and Li, C., 2021, Atorvastatin ester regulates lipid metabolism in hyperlipidemia rats via the PPAR-signaling pathway and HMGCR expression in the liver, Int. J. Mol. Sci., 22 (20), 11107.

[39] Najafi, S., Moshtaghie, A.A., Hassanzadeh, F., Nayeri, H., and Jafari, E., 2023, Design, synthesis, and biological evaluation of novel atorvastatin derivatives, J. Mol. Struct., 1282, 135229.

DOI: https://doi.org/10.22146/ijc.108172